Jubilant Ingrevia Ltd. (JUBLINGREA) fundamentals
Jubilant Ingrevia Ltd. is a listed company in Chemicals & Petrochemicals, part of the Chemicals sector, listed on the NSE as JUBLINGREA (ISIN INE0BY001018). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What Jubilant Ingrevia Ltd. does
Jubilant Ingrevia Limited is a vertically integrated provider of life sciences products and solutions. Its segments include Specialty chemicals, Nutrition & Health solutions and Chemical intermediates. The Specialty Chemicals segment includes bio-pyridine & bio-picolines, fine chemicals, agro chemicals, custom development and manufacturing organization, and microbial control solutions. The Nutrition & Health solutions segment includes nutrition and health ingredients and animal and human nutrition health solutions. The Chemical Intermediates segment includes acetyls and specialty ethanol. In agro chemicals, it offers value-added derivatives, derived from specialty building blocks such as pyridine, picoline and diketene derivatives. This sub-segment includes insecticides, herbicides and fungicides. Its product portfolio includes vital nutritional ingredients, including Vitamin B3, Vitamin B4, Picolinates, and premix formulations designed for both animal and human nutrition.
Valuation and market data
| Last close | ₹658.40 |
|---|---|
| Market capitalisation | ₹10,402 crore |
| Enterprise value | ₹10,979 crore |
| P/E (TTM) | 37.43 |
| Price to book | 3.33 |
| Price to sales (TTM) | 1.32 |
| Book value per share | ₹197.88 |
| Dividend yield | 75.94% |
| Sector | Chemicals |
| Industry | Chemicals & Petrochemicals |
| Listed since | Fri Mar 19 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹4,238 crore | ₹342 crore | ₹268 crore | 16.82 |
| Mar 2025 | ₹4,022 crore | ₹343 crore | ₹263 crore | 16.54 |
| Mar 2024 | ₹4,023 crore | ₹239 crore | ₹162 crore | 10.20 |
| Mar 2023 | ₹4,591 crore | ₹368 crore | ₹253 crore | 15.91 |
| Mar 2022 | ₹4,889 crore | ₹675 crore | ₹452 crore | 28.39 |
Figures are as reported (standalone), in ₹ crore.
Shareholding pattern
As of Jun 2026:
| Promoters | 45.2% |
|---|---|
| Foreign institutions (FII) | 6.5% |
| Mutual funds | 22.4% |
| Other domestic institutions | 2.6% |
| Retail and others | 23.3% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.